Right, the receptor question again, but with numbers this time. I have 12 data points over 12 weeks. The pattern is consistent enough that I do not think it is chance,…
u/ismael_eriksen
Contributes reviews on supplier material. Based in Braga.
member · joined 15 Jun 2025
Overview — page 4 of 5
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 114 points · 8 months ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on is it normal to get fatigue at week 90 in c/retatrutide · 320 points · 9 months ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on week 76 check-in — 12kg down, fatigue manageable, one thing confusing me in c/labresults · 222 points · 10 months ago
the VendorInvestigate and PeptideMeter results differ by 6 points, both inside inter-lab variance
comment on the timeframe thing finally clicked for me and I want to write it down in c/progresspics · 8 points · 10 months ago
Strongly agree. NSV counts.
comment on [Meta] the purity rule is doing its job and people should stop complaining in c/labresults · -33 points · 10 months ago
Removed a chain here.
Yes, exactly this, and it is the bit that took me 83 weeks to accept.
comment on does glucagon actually matter or is it forum lore at this point in c/retatrutide · 213 points · 11 months ago
This is correct. Triple agonism is genuinely different.
comment on week 81 check-in — 12kg down, injection-site soreness manageable, one thing confusing me in c/coa · 5 points · 11 months ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
comment on week 11 check-in — 31kg down, muscle cramps manageable, one thing confusing me in c/retatrutide · 406 points · 11 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on genuine question about appetite that I am slightly embarrassed to ask in c/glp1science · 14 points · 11 months ago
Which paper are you quoting?
comment on is it normal to get early fullness at week 14 in c/coa · -3 points · 1 year ago
What were the related substances listed individually?
comment on [Lab] 7th independent test on BCH, and the trend is the interesting part in c/labresults · 1 points · 1 year ago
Tested 17 batches from QSC over 16 weeks. Spread was 96.2% to 99.2, mostly 96.2. Consistent vendor.
comment on [Lab] 7th independent test on BCH, and the trend is the interesting part in c/labresults · 39 points · 1 year ago
template required: vendor / product / batch / service / method / result
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
comment on [Lab] 7th independent test on BCH, and the trend is the interesting part in c/labresults · 1 points · 1 year ago
This result fits the template perfectly. Logged.
batch. That is the whole post, but I will justify it. Everything else people worry about in c/coa is downstream of it. Titration speed, early fullness, the endless dose…
comment on phase 2 — my 12-week log, condensed into one table in c/retatrutide · 0 points · 1 year ago
heart rate and dose escalation need actual measurements, not impressions
comment on does batch actually matter or is it forum lore at this point in c/coa · 21 points · 1 year ago
comment on [Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2% in c/retatrutide · 51 points · 1 year ago
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
comment on eGFR — my 8-week log, condensed into one table in c/bloodwork · 7 points · 1 year ago
post reference ranges with your numbers, units differ by country and lab
comment on stalled for 17 weeks at 7.5mg and I refuse to panic this time in c/coa · 375 points · 1 year ago
Strongly agree. Mass% and area% are answering different questions on the same document.